Clinical Trials Logo

Clinical Trial Summary

The purpose of φ-PROMISE project is to carry out a cultural adaptation (translate into Finnish and validate) some of the most frequently used shoulder- and elbow-specific patient-reported outcome measures, PROMs. In addition, we aim to investigate which outcome measures are the most relevant for assessing the severity of complaints and treatment outcomes. Also, we will define the Patients Acceptable Symptomatic State (PASS) and the Minimal Important Difference (MID) of the individual outcome measures.


Clinical Trial Description

n/a


Study Design


NCT number NCT05598541
Study type Observational [Patient Registry]
Source Helsinki University Central Hospital
Contact Thomas Ibounig, MD
Phone +358403567693
Email thomas.ibounig@helsinki.fi
Status Recruiting
Phase
Start date October 26, 2022
Completion date October 2024